InflaRx (IFRX) FCF Margin (2022 - 2025)

Historic FCF Margin for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to 8953.06%.

  • InflaRx's FCF Margin fell 11533100.0% to 8953.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 23330.04%, marking a year-over-year increase of 45706100.0%. This contributed to the annual value of 29259.97% for FY2024, which is 305473900.0% up from last year.
  • Per InflaRx's latest filing, its FCF Margin stood at 8953.06% for Q3 2025, which was down 11533100.0% from 19116.12% recorded in Q2 2025.
  • InflaRx's 5-year FCF Margin high stood at 2808019.15% for Q4 2024, and its period low was 474199.34% during Q4 2023.
  • Moreover, its 4-year median value for FCF Margin was 7799.75% (2024), whereas its average is 131800.16%.
  • Per our database at Business Quant, InflaRx's FCF Margin plummeted by 2000000000bps in 2023 and then surged by 2000000000bps in 2024.
  • InflaRx's FCF Margin (Quarter) stood at 137.41% in 2022, then plummeted by -344999bps to 474199.34% in 2023, then soared by 692bps to 2808019.15% in 2024, then plummeted by -100bps to 8953.06% in 2025.
  • Its FCF Margin stands at 8953.06% for Q3 2025, versus 19116.12% for Q2 2025 and 38863.46% for Q1 2025.